Renal Function and Effect of Statin Therapy on Cardiovascular Outcomes in Patients Undergoing Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)

被引:30
|
作者
Natsuaki, Masahiro [2 ]
Furukawa, Yutaka [1 ]
Morimoto, Takeshi [4 ]
Sakata, Ryuzo [3 ]
Kimura, Takeshi [2 ]
机构
[1] Gen Hosp, Kobe City Med Ctr, Dept Cardiovasc Med, Kobe, Hyogo, Japan
[2] Kyoto Univ, Dept Cardiovasc Med, Grad Sch Med, Kyoto, Japan
[3] Kyoto Univ, Dept Cardiovasc Surg, Grad Sch Med, Kyoto, Japan
[4] Kinki Univ, Sch Med, Ctr Gen Internal Med & Emergency Care, Osaka 589, Japan
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 11期
关键词
CHRONIC KIDNEY-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; TYPE-2; DIABETES-MELLITUS; C-REACTIVE PROTEIN; HEART-DISEASE; PREVENTION; EVENTS; ROSUVASTATIN; ATORVASTATIN; HEMODIALYSIS;
D O I
10.1016/j.amjcard.2012.07.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although statin therapy is essential for secondary cardiovascular prevention, the therapeutic effect of statins on cardiovascular outcomes in patients with advanced chronic kidney disease (CKD) after coronary revascularization has not been fully elucidated. In the CREDO-Kyoto Registry Cohort-2, 14,706 patients who underwent first coronary revascularization were divided into 4 strata based on estimated glomerular filtration rate (eGFR) or status of hemodialysis (HD). Patients in each stratum were further divided into 2 groups based on statin therapy at discharge: non-CKD stratum (eGFR >= 60 ml/min/1.73 m(2)), 8,959 patients (statin, n = 4,747; no statin, n = 4,212); mild CKD stratum (eGFR >= 30 to <60 ml/min/1.73 m(2)), 4,567 patients (statin, n = 2,135; no statin, n = 2,432); severe CKD stratum (eGFR <30 ml/min/1.73 m(2)), 608 patients (statin, n = 229; no statin, n = 379); and HD stratum, 572 patients (statin, n = 117; no statin, n = 455). Median follow-up duration was 956 days (interquartile range 699 to 1,245). Adjusted risk for major adverse cardiovascular events (MACEs; composite of cardiovascular death, myocardial infarction, or stoke) was significantly lower in the statin group than in the no-statin group in the non-CKD (hazard ratio 0.8, 95% confidence interval 0.68 to 0.95, p = 0.01) and mild CKD (hazard ratio 0.69, 95% confidence interval 0.56 to 0.84, p = 0.0002) strata. However, a significant association of statin therapy and lower risk for MACEs was not seen in the severe CKD (hazard ratio 0.91, 95% confidence interval 0.6 to 1.38, p = 0.65) and HD (hazard ratio 1.04, 95% confidence interval 0.64 to 1.69, p = 0.87) strata. In conclusion, statin therapy was associated with significantly lower risk for MACEs in patients with non-CKD and mild CKD undergoing coronary revascularization. However, therapeutic benefits of statins were not apparent in patients with severe CKD and HD. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:1568-1577)
引用
收藏
页码:1568 / 1577
页数:10
相关论文
共 50 条
  • [1] Renal Function and Effect of Statin Therapy on Cardiovascular Outcomes in Patients Undergoing Coronary Revascularization: An observation from the CREDO-Kyoto Registry Cohort-2
    Natsuaki, Masahiro
    Furukawa, Yutaka
    Morimoto, Takeshi
    Kimura, Takeshi
    CIRCULATION, 2012, 126 (21)
  • [2] Impact of statin therapy on cardiovascular outcomes after coronary revascularization in elderly patients: observations from the CREDO-kyoto registry cohort-2
    Natsuaki, M.
    Moromoto, T.
    Fukukawa, Y.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 389 - 389
  • [3] Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥80 years of age: Observations from the CREDO-Kyoto Registry Cohort-2
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Furukawa, Yutaka
    Shiomi, Hiroki
    Ono, Koh
    Kimura, Takeshi
    ATHEROSCLEROSIS, 2014, 237 (02) : 821 - 828
  • [4] Impact of polyvascular disease on clinical outcomes in patients undergoing coronary revascularization: An observation from the CREDO-Kyoto Registry Cohort-2
    Morikami, Yuko
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Ono, Koh
    Nakagawa, Yoshihisa
    Furukawa, Yutaka
    Sakata, Ryuzo
    Aota, Masaki
    Okada, Yukikatsu
    Onoe, Masahiko
    Kawasuji, Michio
    Koshiji, Takaaki
    Nakajima, Hiroyuki
    Nishizawa, Junichiro
    Yamanaka, Kazuo
    Yamamoto, Hiroyuki
    Kimura, Takeshi
    ATHEROSCLEROSIS, 2013, 228 (02) : 426 - 431
  • [5] Five-Year Outcomes of Percutaneous Versus Surgical Coronary Revascularization in Patients With Diabetes Mellitus (from the CREDO-Kyoto PCI/CABG Registry Cohort-2)
    Marui, Akira
    Kimura, Takeshi
    Nishiwaki, Noboru
    Mitsudo, Kazuaki
    Komiya, Tatsuhiko
    Hanyu, Michiya
    Shiomi, Hiroki
    Tanaka, Shiro
    Sakata, Ryuzo
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (08): : 1063 - 1072
  • [6] Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3)
    Yamamoto, Ko
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Shiomi, Hiroki
    Matsumura-Nakano, Yukiko
    Nakatsuma, Kenji
    Watanabe, Hiroki
    Yamamoto, Erika
    Kato, Eri
    Fuki, Masayuki
    Yamaji, Kyohei
    Nishikawa, Ryusuke
    Nagao, Kazuya
    Takeji, Yasuaki
    Watanabe, Hirotoshi
    Tazaki, Junichi
    Watanabe, Shin
    Saito, Naritatsu
    Yamazaki, Kazuhiro
    Soga, Yoshiharu
    Komiya, Tatsuhiko
    Ando, Kenji
    Minatoya, Kenji
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Kadota, Kazushige
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 142 : 35 - 43
  • [7] Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2)
    Watanabe, Hiroki
    Shiomi, Hiroki
    Morimoto, Takeshi
    Furukawa, Yutaka
    Nakagawa, Yoshihisa
    Ando, Kenji
    Kadota, Kazushige
    Tazaki, Junichi
    Watanabe, Hirotoshi
    Natsuaki, Masahiro
    Minatoya, Kenji
    Hanyu, Michiya
    Komiya, Tatsuhiko
    Kimura, Takeshi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (01) : 42 - 51
  • [8] Three-year Clinical Outcomes in Patients with Polyvascular Disease Undergoing Coronary Revascularization: A Report from the CREDO-Kyoto Registry Cohort-2
    Morikami, Yuko
    Natsuaki, Masahiro
    Morimoto, Takeshi
    Kimura, Takeshi
    CIRCULATION, 2012, 126 (21)
  • [9] Impact of coronary artery bypass surgery on long-term outcomes in patients with heart failure: from the CREDO-Kyoto PCI/CABG registry Cohort-2
    Marui, A.
    Shiomi, H.
    Kimura, T.
    Tanaka, S.
    Hanyu, M.
    Komiya, T.
    Kita, T.
    Sakata, R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 833 - 834
  • [10] Intensity of Statin Therapy, Achieved Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization - Perspectives From the CREDO-Kyoto Registry Cohort-2
    Natsuaki, Masahiro
    Furukawa, Yutaka
    Morimoto, Takeshi
    Nakagawa, Yoshihisa
    Ono, Koh
    Kaburagi, Satoshi
    Inada, Tsukasa
    Mitsuoka, Hirokazu
    Taniguchi, Ryoji
    Nakano, Akira
    Kita, Tow
    Sakata, Ryuzo
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2012, 76 (06) : 1369 - 1379